Retatrutide is a novel investigational compound known for its activity as a triple agonist of GLP-1, GIP, and glucagon receptors. It is currently being studied for its multifaceted impact on metabolic regulation, including appetite suppression, weight management, and insulin sensitivity.
Early research suggests that Retatrutide may play a role in modulating energy expenditure and enhancing glycemic control. Studies continue to explore its broader implications in treating metabolic disorders.
Compound Details
CAS Number |
2381089-83-2 |
PubChem CID |
165676551 |
Molecular Formula |
C211H327N51O63 |
Composition |
Lyophilized powder |
Storage |
Following reconstitution, store at refrigerated temperatures in a sealed, light-resistant container to maintain stability. |